CDCA7
Cell division cycle-associated protein 7
Also known as: CDCA7_HUMAN, FLJ14736, JPO1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BWT1
- Gene
- CDCA7
- Ensembl
- ENSG00000144354
- Chromosome
- 2
- Canonical length
- 371 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene was identified as a c-Myc responsive gene, and behaves as a direct c-Myc target gene. Overexpression of this gene is found to enhance the transformation of lymphoblastoid cells, and it complements a transformation-defective Myc Box II mutant, suggesting its involvement in c-Myc-mediated cell transformation. Two alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
371 residues, UniProt reviewed canonical sequence.
>Q9BWT1|CDCA7
1 MDARRVPQKD LRVKKNLKKF RYVKLISMET SSSSDDSCDS FASDNFANTR LQSVREGCRT
61 RSQCRHSGPL RVAMKFPARS TRGATNKKAE SRQPSENSVT DSNSDSEDES GMNFLEKRAL
121 NIKQNKAMLA KLMSELESFP GSFRGRHPLP GSDSQSRRPR RRTFPGVASR RNPERRARPL
181 TRSRSRILGS LDALPMEEEE EEDKYMLVRK RKTVDGYMNE DDLPRSRRSR SSVTLPHIIR
241 PVEEITEEEL ENVCSNSREK IYNRSLGSTC HQCRQKTIDT KTNCRNPDCW GVRGQFCGPC
301 LRNRYGEEVR DALLDPNWHC PPCRGICNCS FCRQRDGRCA TGVLVYLAKY HGFGNVHAYL
361 KSLKQEFEMQ ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDCA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- thymus: 42 nTPM
- tonsil: 34 nTPM
- lymph node: 29 nTPM
- small intestine: 27 nTPM
- duodenum: 23 nTPM
- rectum: 23 nTPM
Single-cell type
- enteric stem cells: 207 nCPM
- paneth cells: 170 nCPM
- enteric transient amplifying cells: 110 nCPM
- gastric progenitor cells: 104 nCPM
- leydig cells: 93 nCPM
- decidual stromal cells: 63 nCPM
Immune cell
- T-reg: 8.8 nTPM
- memory CD8 T-cell: 6.1 nTPM
- myeloid DC: 3.8 nTPM
- NK-cell: 3.6 nTPM
- memory CD4 T-cell: 3.2 nTPM
- total PBMC: 2.5 nTPM
Brain region
- choroid plexus: 12 nTPM
- hypothalamus: 2.1 nTPM
- thalamus: 2 nTPM
- white matter: 1.8 nTPM
- midbrain: 1.5 nTPM
- medulla oblongata: 1.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDCA7.
Disease | AllUniProt
Conditions CDCA7 is implicated in, by any mechanism.
- Immunodeficiency-centromeric instability-facial anomalies syndrome 3 (ICF3) MIM:616910
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 289 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency-centromeric instability-facial anomalies syndrome 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- regulation of cell population proliferation
- regulation of DNA-templated transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDCA7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDCA7 as an antibody target. Whether an autoantibody or antibody against CDCA7 could matter depends on whether native CDCA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDCA7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDCA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...